FOSL1 and central nervous system cancer: Importantly, high expression levels were associated with worse prognosis in IDH-wt tumors (Figure 1F), thus suggesting that FOSL1 could represent not only a key regulator of the glioma-intrinsic MES signature, but also a putative key player in MES glioma pathogenesis.